Antiandrogens
Aspirin
Bamlanivimab
Bromhexine
Budesonide
Casirivimab/i..
Colchicine
Conv. Plasma
Curcumin
Favipiravir
Fluvoxamine
Hydroxychloro..
Iota-carragee..
Ivermectin
Melatonin
Metformin
Molnupiravir
Nigella Sativa
Nitazoxanide
Paxlovid
Povidone-Iod..
Probiotics
Proxalutamide
Quercetin
Remdesivir
Sotrovimab
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback
Home
Top
Algeria
Argentina
Australia
Bahrain
Bangladesh
Belarus
Belize
Benin
Bolivia
Botswana
Brazil
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Central Africa..
Chad
Chile
China
Colombia
Congo
Costa Rica
Cuba
Czech Republic
Democratic Rep..
Djibouti
Dominican Repu..
Ecuador
Egypt
El Salvador
Eritrea
Gabon
Germany
Ghana
Greece
Guatemala
Guinea
Guinea-Bissau
Honduras
Iceland
India
Indonesia
Iran
Israel
Jamaica
Japan
Lebanon
Luxembourg
Madagascar
Malaysia
Mali
Mexico
Morocco
Namibia
New Zealand
Nicaragua
Niger
Nigeria
North Macedonia
Oman
Pakistan
Panama
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Senegal
Singapore
Slovakia
South Africa
South Korea
Thailand
Tunisia
Turkey
USA
Ukraine
United Arab Em..
United Kingdom
Venezuela
Vietnam
Yemen
Zimbabwe

Feedback
Home   COVID-19 treatment studies  COVID-19 treatment studies  COVID-19 studies   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Metformin (meta)
Aspirin (meta) Molnupiravir (meta)
Bamlanivimab (meta) Nigella Sativa (meta)
Bromhexine (meta) Nitazoxanide (meta)
Budesonide (meta) Paxlovid (meta)
Casirivimab/i.. (meta) Povidone-Iod.. (meta)
Colchicine (meta) Probiotics (meta)
Conv. Plasma (meta) Proxalutamide (meta)
Curcumin (meta) Quercetin (meta)
Favipiravir (meta) Remdesivir (meta)
Fluvoxamine (meta) Sotrovimab (meta)
Hydroxychloro.. (meta) Vitamin A (meta)
Iota-carragee.. (meta) Vitamin C (meta)
Ivermectin (meta) Vitamin D (meta)
Melatonin (meta) Zinc (meta)

Other Treatments Global Adoption
Global adoption of COVID-19 early treatments
Treatment
Improvement
  (early)
Studies
  (early)
PLPaxlovid 95% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FVFluvoxamine 89% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V.DVitamin D 86% 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NSNigella Sativa 84% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BUBudesonide 82% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BHBromhexine 79% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V.AVitamin A 79% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QQuercetin 79% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BLBamlanivimab 79% 6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MTMelatonin 78% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZnZinc 74% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PXProxalutamide 73% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCCurcumin 71% 6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PIPovidone-Iodine 71% 7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AAAntiandrogen 68% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CICasirivimab/im.. 68% 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SSotrovimab 67% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IVMIvermectin 66% 29
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(H)CQHydroxychloro.. 64% 33
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MPMolnupiravir 55% 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NZNitazoxanide 49% 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FPVFavipiravir 47% 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V.CVitamin C 43% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PBProbiotics 34% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RDRemdesivir - 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Global adoption of early treatments. Studies, improvement, and adoption refer to early treatment only. Countries ordered by population. Official:
 
  Unofficial:
 
References
Algeria
(Hydroxy)chloroquine - official - country-wide adoption
Argentina
Ivermectin - unofficial - mixed usage - Jan 26, 2021
Australia
Budesonide - official - country-wide adoption
Casirivimab/imdevimab - official - country-wide adoption
Sotrovimab - official - country-wide adoption
Remdesivir - official - country-wide adoption
Bahrain
(Hydroxy)chloroquine - official - country-wide adoption
Bangladesh
Ivermectin - official - country-wide adoption
Belarus
(Hydroxy)chloroquine - unofficial - mixed usage
Belize
Ivermectin - official - country-wide adoption - used for serious cases - Dec 18, 2020
Benin
Casirivimab/imdevimab - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Bolivia
Ivermectin - official - country-wide adoption
Botswana
Ivermectin - unofficial - mixed usage
Brazil
Ivermectin - unofficial - used in some regions - Jan 26, 2021
Bulgaria
Ivermectin - official - country-wide adoption
Burkina Faso
(Hydroxy)chloroquine - official - country-wide adoption
Burundi
Casirivimab/imdevimab - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Cambodia
Ivermectin - official - country-wide adoption
Cameroon
Casirivimab/imdevimab - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Canada
Bamlanivimab - official - country-wide adoption
Casirivimab/imdevimab - official - country-wide adoption
Sotrovimab - official - country-wide adoption
Central African Republic
Casirivimab/imdevimab - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Chad
Casirivimab/imdevimab - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Chile
(Hydroxy)chloroquine - unofficial - mixed usage
China
(Hydroxy)chloroquine - official - country-wide adoption - CQ is used instead of HCQ
https://www.chinalawtranslate.com/en/coronavirus-treatment-plan-7/ (Internet Archive)
http://rs.yiigle.com/yufabiao/1246637.htm (Internet Archive)
https://www.archyde.com/china-approves-chloroquine-instead-of-hydroxychloroquine-against-c.. (Internet Archive)
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
Probiotics - official - country-wide adoption
Colombia
Ivermectin - unofficial - used in many regions
Congo
(Hydroxy)chloroquine - official - country-wide adoption
Remdesivir - official - country-wide adoption
Costa Rica
(Hydroxy)chloroquine - official - country-wide adoption
Cuba
(Hydroxy)chloroquine - official - country-wide adoption
Czech Republic
Ivermectin - official - isolated use - authorized, but reportedly almost no use
(Hydroxy)chloroquine - official - country-wide adoption
Democratic Republic of Congo
(Hydroxy)chloroquine - official - country-wide adoption
Djibouti
(Hydroxy)chloroquine - official - country-wide adoption
Dominican Republic
Ivermectin - official - country-wide adoption - Sep 30, 2020
Ecuador
(Hydroxy)chloroquine - unofficial - mixed usage
Egypt
Ivermectin - official - country-wide adoption - Nov 30, 2020
(Hydroxy)chloroquine - unofficial - mixed usage
El Salvador
Ivermectin - official - country-wide adoption
(Hydroxy)chloroquine - unofficial - mixed usage
Eritrea
(Hydroxy)chloroquine - official - country-wide adoption
Gabon
(Hydroxy)chloroquine - official - country-wide adoption
Germany
Fluvoxamine - unofficial - used in some regions
Budesonide - unofficial - used in some regions
Ivermectin - unofficial - isolated use - Dec 31, 2020
(Hydroxy)chloroquine - unofficial - mixed usage
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
Ghana
(Hydroxy)chloroquine - official - country-wide adoption
Remdesivir - official - country-wide adoption
Greece
(Hydroxy)chloroquine - official - country-wide adoption
Guatemala
Ivermectin - official - country-wide adoption - Jan 23, 2021
Guinea
Casirivimab/imdevimab - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Guinea-Bissau
(Hydroxy)chloroquine - official - country-wide adoption
Honduras
Ivermectin - official - country-wide adoption - Apr 23, 2020
Iceland
(Hydroxy)chloroquine - unofficial - mixed usage
India
Budesonide - official - country-wide adoption
Sotrovimab - official - country-wide adoption
Ivermectin - unofficial - used in many regions
(Hydroxy)chloroquine - official - mixed usage
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
Favipiravir - official - isolated use
Remdesivir - official - isolated use
Indonesia
Ivermectin - official - mixed usage
(Hydroxy)chloroquine - official - mixed usage
Iran
Ivermectin - unofficial - mixed usage - now manufacturing their own ivermectin, but the level of usage is unclear
(Hydroxy)chloroquine - official - country-wide adoption
Israel
(Hydroxy)chloroquine - unofficial - mixed usage
Jamaica
Ivermectin - official - isolated use - authorized for off-label use, availability delayed
Japan
Casirivimab/imdevimab - official - country-wide adoption
Sotrovimab - official - country-wide adoption
Ivermectin - unofficial - used in some regions - May 18, 2020
Lebanon
Ivermectin - official - country-wide adoption - Jan 27, 2021
Luxembourg
(Hydroxy)chloroquine - unofficial - mixed usage
Madagascar
(Hydroxy)chloroquine - official - country-wide adoption
Malaysia
Ivermectin - unofficial - isolated use
(Hydroxy)chloroquine - unofficial - mixed usage
Favipiravir - official - country-wide adoption
Mali
(Hydroxy)chloroquine - official - country-wide adoption
Mexico
Ivermectin - official - mixed usage - Dec 29, 2020
Morocco
(Hydroxy)chloroquine - official - country-wide adoption
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
Namibia
Remdesivir - official - country-wide adoption
New Zealand
Budesonide - official - country-wide adoption
Nicaragua
Ivermectin - official - country-wide adoption - Jan 25, 2021
Niger
(Hydroxy)chloroquine - official - country-wide adoption
Nigeria
Ivermectin - unofficial - used in many regions
(Hydroxy)chloroquine - official - country-wide adoption
North Macedonia
Ivermectin - official - mixed usage - Jan 15, 2021
Oman
(Hydroxy)chloroquine - unofficial - mixed usage
Pakistan
(Hydroxy)chloroquine - unofficial - mixed usage
Panama
Ivermectin - official - country-wide adoption
(Hydroxy)chloroquine - unofficial - mixed usage
Paraguay
Proxalutamide - official - country-wide adoption
Ivermectin - official - used in some regions
Peru
Ivermectin - unofficial - used in some regions - was widely used but later restricted, a study shows 14x reduction in excess deaths when used and 13x increase when restricted - May 8, 2020
Philippines
Ivermectin - unofficial - isolated use
Poland
Budesonide - official - country-wide adoption - Apr 26, 2021
Remdesivir - official - country-wide adoption
Portugal
Ivermectin - unofficial - used in some regions
(Hydroxy)chloroquine - unofficial - mixed usage
Qatar
(Hydroxy)chloroquine - official - country-wide adoption
Romania
Favipiravir - official - country-wide adoption
Russia
Budesonide - official - country-wide adoption
Favipiravir - official - country-wide adoption
Saudi Arabia
Budesonide - official - country-wide adoption
Casirivimab/imdevimab - official - country-wide adoption
Sotrovimab - official - country-wide adoption
(Hydroxy)chloroquine - unofficial - mixed usage
Favipiravir - official - country-wide adoption
Senegal
(Hydroxy)chloroquine - official - country-wide adoption
Singapore
Casirivimab/imdevimab - official - country-wide adoption
Sotrovimab - official - country-wide adoption
Slovakia
Ivermectin - official - mixed usage - while approved, press has been divided, censorship is common, and access is limited but improving - Jan 27, 2021
South Africa
Ivermectin - unofficial - mixed usage - may be prescribed without section 21 approval from 3/17/21, compounding allowed from 4/7/21 - Jan 27, 2021
South Korea
(Hydroxy)chloroquine - official - country-wide adoption
Thailand
Ivermectin - unofficial - isolated use
Favipiravir - official - country-wide adoption
Tunisia
(Hydroxy)chloroquine - unofficial - mixed usage
Turkey
(Hydroxy)chloroquine - official - country-wide adoption
Favipiravir - official - country-wide adoption
USA
Fluvoxamine - unofficial - isolated use
Bamlanivimab - official - country-wide adoption
Casirivimab/imdevimab - official - country-wide adoption
Sotrovimab - official - country-wide adoption
Ivermectin - unofficial - used in some regions - Oct 31, 2020
Ukraine
Ivermectin - official - mixed usage
(Hydroxy)chloroquine - official - country-wide adoption
United Arab Emirates
Sotrovimab - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Favipiravir - official - country-wide adoption
United Kingdom
Budesonide - official - country-wide adoption
Casirivimab/imdevimab - official - country-wide adoption
Sotrovimab - official - country-wide adoption
Molnupiravir - official - country-wide adoption
Venezuela
Ivermectin - official - country-wide adoption
(Hydroxy)chloroquine - official - country-wide adoption
Favipiravir - official - country-wide adoption
Vitamin C - official - country-wide adoption
Remdesivir - official - country-wide adoption
Vietnam
Molnupiravir - official - country-wide adoption
Favipiravir - official - country-wide adoption
Yemen
(Hydroxy)chloroquine - unofficial - isolated use
Zimbabwe
Ivermectin - official - country-wide adoption - Jan 28, 2021
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit